Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis.

Maertens L, Erpicum C, Detry B, Blacher S, Lenoir B, Carnet O, Péqueux C, Cataldo D, Lecomte J, Paupert J, Noel A.

PLoS One. 2014 Sep 15;9(9):e106976. doi: 10.1371/journal.pone.0106976. eCollection 2014.

2.

Cell invasion in the spheroid sprouting assay: a spatial organisation analysis adaptable to cell behaviour.

Blacher S, Erpicum C, Lenoir B, Paupert J, Moraes G, Ormenese S, Bullinger E, Noel A.

PLoS One. 2014 May 7;9(5):e97019. doi: 10.1371/journal.pone.0097019. eCollection 2014.

3.

Sunitinib inhibits inflammatory corneal lymphangiogenesis.

Detry B, Blacher S, Erpicum C, Paupert J, Maertens L, Maillard C, Munaut C, Sounni NE, Lambert V, Foidart JM, Rakic JM, Cataldo D, Noël A.

Invest Ophthalmol Vis Sci. 2013 May 3;54(5):3082-93. doi: 10.1167/iovs.12-10856.

PMID:
23580490
4.

Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.

Lecomte J, Masset A, Blacher S, Maertens L, Gothot A, Delgaudine M, Bruyère F, Carnet O, Paupert J, Illemann M, Foidart JM, Lund IK, Høyer-Hansen G, Noel A.

Neoplasia. 2012 Oct;14(10):943-51.

5.

Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase.

Detry B, Erpicum C, Paupert J, Blacher S, Maillard C, Bruyère F, Pendeville H, Remacle T, Lambert V, Balsat C, Ormenese S, Lamaye F, Janssens E, Moons L, Cataldo D, Kridelka F, Carmeliet P, Thiry M, Foidart JM, Struman I, Noël A.

Blood. 2012 May 24;119(21):5048-56. doi: 10.1182/blood-2011-12-400267. Epub 2012 Apr 6.

6.

Digging deeper into lymphatic vessel formation in vitro and in vivo.

Detry B, Bruyère F, Erpicum C, Paupert J, Lamaye F, Maillard C, Lenoir B, Foidart JM, Thiry M, Noël A.

BMC Cell Biol. 2011 Jun 24;12:29. doi: 10.1186/1471-2121-12-29.

7.

Lymphangiogenesis in post-natal tissue remodeling: lymphatic endothelial cell connection with its environment.

Paupert J, Sounni NE, Noël A.

Mol Aspects Med. 2011 Apr;32(2):146-58. doi: 10.1016/j.mam.2011.04.002. Epub 2011 Apr 29. Review.

PMID:
21549745
8.

Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization.

Lecomte J, Louis K, Detry B, Blacher S, Lambert V, Bekaert S, Munaut C, Paupert J, Blaise P, Foidart JM, Rakic JM, Krane SM, Noel A.

Cell Mol Life Sci. 2011 Feb;68(4):677-86. doi: 10.1007/s00018-010-0476-6. Epub 2010 Aug 11.

PMID:
20700625
9.

Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features.

Paupert J, Mansat-De Mas V, Demur C, Salles B, Muller C.

Cell Cycle. 2008 Apr 15;7(8):1047-53. Epub 2008 Jan 18.

10.

New rationales for using TGFbeta inhibitors in radiotherapy.

Andarawewa KL, Paupert J, Pal A, Barcellos-Hoff MH.

Int J Radiat Biol. 2007 Nov-Dec;83(11-12):803-11. Review.

PMID:
18058368
11.

Transport of the leaderless protein Ku on the cell surface of activated monocytes regulates their migratory abilities.

Paupert J, Dauvillier S, Salles B, Muller C.

EMBO Rep. 2007 Jun;8(6):583-8. Epub 2007 May 11.

12.

The double life of the Ku protein: facing the DNA breaks and the extracellular environment.

Muller C, Paupert J, Monferran S, Salles B.

Cell Cycle. 2005 Mar;4(3):438-41. Epub 2005 Mar 31. Review.

13.

The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9.

Monferran S, Paupert J, Dauvillier S, Salles B, Muller C.

EMBO J. 2004 Oct 1;23(19):3758-68. Epub 2004 Sep 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk